Pfizer (PFE) Long-Term Investments (2016 - 2025)
Pfizer (PFE) has disclosed Long-Term Investments for 17 consecutive years, with $1.6 billion as the latest value for Q4 2025.
- Quarterly Long-Term Investments fell 27.24% to $1.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, down 27.24% year-over-year, with the annual reading at $1.6 billion for FY2025, 27.24% down from the prior year.
- Long-Term Investments for Q4 2025 was $1.6 billion at Pfizer, down from $2.1 billion in the prior quarter.
- The five-year high for Long-Term Investments was $20.9 billion in Q3 2021, with the low at $224.0 million in Q1 2025.
- Average Long-Term Investments over 5 years is $8.1 billion, with a median of $7.9 billion recorded in 2024.
- The sharpest move saw Long-Term Investments skyrocketed 131.55% in 2023, then crashed 97.17% in 2025.
- Over 5 years, Long-Term Investments stood at $5.1 billion in 2021, then skyrocketed by 114.17% to $10.8 billion in 2022, then plummeted by 65.53% to $3.7 billion in 2023, then tumbled by 40.28% to $2.2 billion in 2024, then decreased by 27.24% to $1.6 billion in 2025.
- According to Business Quant data, Long-Term Investments over the past three periods came in at $1.6 billion, $2.1 billion, and $1.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.